Genetic defects in thyroid hormone synthesis

被引:30
作者
Gillam, MP [1 ]
Kopp, P [1 ]
机构
[1] Northwestern Univ, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA
关键词
D O I
10.1097/00008480-200108000-00014
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Thyroid hormone synthesis requires a normally developed thyroid gland, a properly functioning hypothalamic-pituitary-thyroid axis, and sufficient iodine intake. This article focuses on genetic defects in this axis. Defects that are primarily of developmental origin are discussed in our associated article in this issue [1]. Defects in hormone synthesis usually are associated with the development of a goiter, provided that the bioactivity and action of thyrotropin (TSH). are not impaired. In contrast, hypoplasia of the gland may be caused by developmental defects, bioinactive TSH, or resistance to TSH at the level of the receptor or its signaling pathway. At the other end of the spectrum, hyperthyroidism may result from gain of function mutations in genes regulating growth and function. (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:364 / 372
页数:9
相关论文
共 81 条
[1]   IDENTIFICATION OF A MUTATION IN THE CODING SEQUENCE OF THE HUMAN THYROID PEROXIDASE GENE CAUSING CONGENITAL GOITER [J].
ABRAMOWICZ, MJ ;
TARGOVNIK, HM ;
VARELA, V ;
COCHAUX, P ;
KRAWIEC, L ;
PISAREV, MA ;
PROPATO, FVE ;
JUVENAL, G ;
CHESTER, HA ;
VASSART, G .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1200-1204
[2]  
[Anonymous], 1999, CURR OPIN ENDOCRINOL
[3]   Two decades of screening for congenital hypothyroidism in the Netherlands: TPO gene mutations in total iodide organification defects (an update) [J].
Bakker, B ;
Bikker, H ;
Vulsma, T ;
De Randamie, JSE ;
Wiedijk, BM ;
De Vijlder, JJM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) :3708-3712
[4]   Maternal isodisomy for chromosome 2p causing severe congenital hypothyroidism [J].
Bakker, B ;
Bikker, H ;
Hennekam, RCM ;
Lommen, EJP ;
Schipper, MGJ ;
Vulsma, T ;
de Vijlder, JJM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1164-1168
[5]   DECREASED RECEPTOR-BINDING OF BIOLOGICALLY INACTIVE THYROTROPIN IN CENTRAL HYPOTHYROIDISM - EFFECT OF TREATMENT WITH THYROTROPIN-RELEASING-HORMONE [J].
BECKPECCOZ, P ;
AMR, S ;
MENEZESFERREIRA, MM ;
FAGLIA, G ;
WEINTRAUB, BD .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (17) :1085-1090
[6]   IDENTIFICATION OF 5 NOVEL INACTIVATING MUTATIONS IN THE HUMAN THYROID PEROXIDASE GENE BY DENATURING GRADIENT GEL-ELECTROPHORESIS [J].
BIKKER, H ;
VULSMA, T ;
BAAS, F ;
DEVIJLDER, JJM .
HUMAN MUTATION, 1995, 6 (01) :9-16
[7]   A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism [J].
Camacho, P ;
Gordon, D ;
Chiefari, E ;
Yong, S ;
DeJong, S ;
Pitale, S ;
Russo, D ;
Filetti, S .
THYROID, 2000, 10 (11) :1009-1012
[8]  
Collu Robert, 1997, Journal of Clinical Endocrinology and Metabolism, V82, P1361
[9]  
DACOUVOUTETAKIS C, 1990, AM J HUM GENET, V46, P988
[10]   Cloning and characterization of the thyroid iodide transporter [J].
Dai, G ;
Levy, O ;
Carrasco, N .
NATURE, 1996, 379 (6564) :458-460